OBJECTIVES: To assess HIV prevalence and risk factors for HIV infection, to investigate condom use among registered female commercial sex workers (CSWs) in Senegal, West Africa, and to examine the association between previous HIV testing, knowledge of HIV serostatus and condom use with both regular sex partners and clients within this population. METHODS: A cross-sectional study was conducted at three sexually transmitted disease clinics among 1052 Senegalese registered CSWs between 2000 and 2004. Inperson interviews soliciting information concerning demographic characteristics, medical history, sexual behaviour with clients and regular partners, and previous HIV testing history were performed. Blood samples were collected for determination of HIV-1 and/or HIV-2 serostatus. Multivariable, Poisson and log-binomial models were used to calculate prevalence ratios. RESULTS: The overall HIV prevalence was 19.8%. Over 95% of CSWs reported always using a condom with clients, but only 18% reported always using a condom with their regular partners. A history of previous HIV testing was not associated with condom use with clients (adjusted prevalence ratio (APR) = 0.98, 95% confidence intervals, CI: 0.90 to 1.06). However, prior HIV testing was associated with decreased condom use with their regular partners (APR = 0.44, 95% CI: 0.28 to 0.69), especially in women who tested HIV negative (APR = 0.17, 95% CI: 0.08 to 0.36). CONCLUSIONS: CSWs in Senegal have a high HIV prevalence; therefore preventing HIV transmission from this population to the general population is important. Condom use with regular partners is low among registered CSWs in Senegal, and a prior HIV negative test is associated with even less condom use with regular partners. Intervention efforts to increase condom use with regular sexual partners are needed.
OBJECTIVES: To assess HIV prevalence and risk factors for HIV infection, to investigate condom use among registered female commercial sex workers (CSWs) in Senegal, West Africa, and to examine the association between previous HIV testing, knowledge of HIV serostatus and condom use with both regular sex partners and clients within this population. METHODS: A cross-sectional study was conducted at three sexually transmitted disease clinics among 1052 Senegalese registered CSWs between 2000 and 2004. Inperson interviews soliciting information concerning demographic characteristics, medical history, sexual behaviour with clients and regular partners, and previous HIV testing history were performed. Blood samples were collected for determination of HIV-1 and/or HIV-2 serostatus. Multivariable, Poisson and log-binomial models were used to calculate prevalence ratios. RESULTS: The overall HIV prevalence was 19.8%. Over 95% of CSWs reported always using a condom with clients, but only 18% reported always using a condom with their regular partners. A history of previous HIV testing was not associated with condom use with clients (adjusted prevalence ratio (APR) = 0.98, 95% confidence intervals, CI: 0.90 to 1.06). However, prior HIV testing was associated with decreased condom use with their regular partners (APR = 0.44, 95% CI: 0.28 to 0.69), especially in women who tested HIV negative (APR = 0.17, 95% CI: 0.08 to 0.36). CONCLUSIONS: CSWs in Senegal have a high HIV prevalence; therefore preventing HIV transmission from this population to the general population is important. Condom use with regular partners is low among registered CSWs in Senegal, and a prior HIV negative test is associated with even less condom use with regular partners. Intervention efforts to increase condom use with regular sexual partners are needed.
Authors: Rupert Kaul; Joshua Kimani; Nico J Nagelkerke; Karoline Fonck; Florence Keli; Kelly S MacDonald; Allan R Ronald; Francis A Plummer; Job J Bwayo; Elizabeth N Ngugi; Marleen Temmerman; Stephen Moses Journal: J Acquir Immune Defic Syndr Date: 2002-05-01 Impact factor: 3.731
Authors: Peter D Ghys; Mamadou O Diallo; Virginie Ettiègne-Traoré; Kouamé Kalé; Oussama Tawil; Michel Caraël; Moussa Traoré; Guessan Mah-Bi; Kevin M De Cock; Stefan Z Wiktor; Marie Laga; Alan E Greenberg Journal: AIDS Date: 2002-01-25 Impact factor: 4.177
Authors: Judith M Vandepitte; Faustin Malele; Dieu-Merçi Kivuvu; Samuel Edidi; Jérémie Muwonga; François Lepira; Said Abdellati; Joelle Kabamba; Catherine Van Overloop; Anne Buvé Journal: Sex Transm Dis Date: 2007-04 Impact factor: 2.830
Authors: C M Lowndes; M Alary; C A Gnintoungbé; E Bédard; L Mukenge; N Geraldo; P Jossou; E Lafia; F Bernier; E Baganizi; J Joly; E Frost; S Anagonou Journal: AIDS Date: 2000-11-10 Impact factor: 4.177
Authors: C M Lowndes; M Alary; H Meda; C A B Gnintoungbé; L Mukenge-Tshibaka; C Adjovi; A Buvé; L Morison; M Laourou; L Kanhonou; S Anagonou Journal: Sex Transm Infect Date: 2002-04 Impact factor: 3.519
Authors: Mwumvaneza Mutagoma; Malamba S Samuel; Catherine Kayitesi; Antoine R Gasasira; Bassirou Chitou; Kimberly Boer; Bethany Hedt-Gauthier; Neil Gupta; Joseph Ntaganira; Sabin Nsanzimana Journal: Int J STD AIDS Date: 2017-01-12 Impact factor: 1.359
Authors: Maria F Gallo; Markus J Steiner; Marcia M Hobbs; Mark A Weaver; Theresa Hatzell Hoke; Kathleen Van Damme; Denise J Jamieson; Maurizio Macaluso Journal: AIDS Behav Date: 2010-12
Authors: Angela Robertson Bazzi; Gudelia Rangel; Gustavo Martinez; Monica D Ulibarri; Jennifer L Syvertsen; Samuel A Bazzi; Scott Roesch; Heather A Pines; Steffanie A Strathdee Journal: Am J Epidemiol Date: 2015-03-13 Impact factor: 4.897
Authors: Alexis M Roth; Joshua G Rosenberger; Devon J Hensel; Sarah E Wiehe; J Dennis Fortenberry; Karla D Wagner Journal: Sex Health Date: 2016-04 Impact factor: 2.706
Authors: Jennifer L Syvertsen; Angela M Robertson; Lawrence A Palinkas; M Gudelia Rangel; Gustavo Martinez; Steffanie A Strathdee Journal: Cult Health Sex Date: 2013-03-11